sever
sepsi
septic
shock
primari
caus
death
patient
intens
care
unit
icu
investig
upon
genet
suscept
profil
system
complic
sever
infect
field
increas
scientif
interest
particularli
adapt
immun
system
compromis
immatur
innat
immun
play
key
role
immedi
defens
invas
pathogen
mannosebind
lectin
mbl
serum
protein
recogn
wide
rang
pathogen
microorgan
activ
complement
cascad
via
antibodyindepend
pathway
human
harbor
mutat
mbl
gene
result
reduc
plasmat
level
activ
increas
risk
infect
acquisit
larg
document
mbldefici
patient
real
impact
form
innat
immunosuppress
upon
clinic
outcom
clear
critic
ill
patient
higher
incid
wors
prognosi
sever
sepsissept
shock
appear
associ
lowproduc
haplotyp
howev
excess
mbl
activ
might
also
harm
due
possibl
unbalanc
proinflammatori
respons
addit
host
injuri
strategi
replac
therapi
critic
ill
patient
sever
infect
investig
still
far
appli
clinic
practic
despit
diffus
effect
care
bundl
implement
new
technolog
abl
support
organ
function
sever
sepsi
septic
shock
still
repres
lead
caus
intens
care
unit
icu
admiss
case
fatal
rate
system
inflamm
surround
multiorgan
failur
septic
shock
result
maladapt
unbal
earli
antimicrobi
immun
reaction
uncontrol
local
infect
inflamm
innat
immun
system
primit
firstlin
organ
respons
invas
pathogen
interact
homeostat
pattern
includ
inflamm
coagul
earli
activ
immun
respons
mediat
solubl
pattern
recognit
molecul
addit
complement
protein
cytokin
coagul
factor
activ
humor
cellular
effector
identifi
neutral
invas
pathogen
mannosebind
lectin
mbl
solubl
pattern
recognit
molecul
activ
lectin
pathway
complement
system
subsequ
inflammatori
mechan
low
mbl
plasmat
level
mainli
due
genet
influenc
larg
describ
associ
suscept
invas
infect
poor
outcom
hand
excess
activ
ancient
protect
system
may
respons
detriment
unbalanc
inflammatori
coagul
respons
observ
inflammatori
diseas
transplant
reject
diabet
nephropathi
mani
author
investig
whether
mbl
may
influenc
suscept
common
pathogen
develop
sever
infect
still
consensu
clinic
relev
defici
indic
replac
therapi
purpos
review
summar
result
relev
recent
studi
role
mbl
sever
sepsi
septic
shock
investig
mannosebind
lectin
serum
calciumdepend
protein
synthes
liver
detect
site
inflamm
particularli
epitheliallin
fluid
small
amount
protein
also
produc
organ
kidney
thymu
tonsil
small
intestin
vagina
mbl
collectin
collagenlik
lectin
character
highord
oligomer
structur
essenti
function
interact
mblassoci
serin
proteas
masp
mbl
harbor
carbohydr
recognit
domain
crd
bind
specif
carbohydr
ie
mannos
nacetylglucosamin
expos
pathogen
agent
surfac
therefor
call
patternrecognit
molecul
subsequ
masp
mainli
abl
trigger
lectin
complement
pathway
cleav
form
convertas
complement
system
may
activ
three
pathway
classic
altern
one
antibodi
depend
belong
adapt
immun
respons
lectin
one
antibodi
independ
part
innat
immun
system
come
play
within
first
hour
microorgan
contact
figur
mbl
play
central
role
firstlin
defens
invad
pathogen
trigger
complement
system
directli
mediat
opsonophagocytosi
possibl
function
tolllik
receptor
coreceptor
human
two
gene
might
code
mbl
gene
function
locat
long
arm
chromosom
mbl
defici
may
due
presenc
singl
nucleotid
polymorph
snp
either
genecod
promot
region
wildtyp
gene
call
homozyg
haplotyp
aa
instead
variant
allel
wide
classifi
three
point
mutat
involv
exon
identifi
allel
b
codon
c
codon
codon
addit
mani
snp
may
affect
promot
region
determin
low
mbl
protein
serum
level
activ
variant
hl
yx
pq
even
though
mutat
could
combin
exon
allel
seven
haplotyp
typic
found
human
genom
polymorph
determin
product
unstabl
protein
shorter
halflif
mainli
due
absenc
highord
oligomer
structur
variant
abl
effici
activ
complement
pathway
healthi
individu
genotyp
aa
gener
present
mbl
level
ngml
newborn
protein
detect
concentr
twothird
mother
normal
level
reach
within
month
mbl
level
influenc
age
circadian
cycl
physic
exercis
inflamm
increas
fold
baselin
level
mbl
defici
gener
defin
plasmat
protein
level
ngml
mbl
function
lower
u
l
deposit
detect
pulmonari
mbl
concentr
quit
difficult
author
report
bronchoalveolar
lavag
bal
level
rang
ngml
result
correct
dilut
factor
ie
urea
lung
protein
known
lung
concentr
could
explain
larg
distanc
minimum
concentr
need
activ
complement
protein
ngml
plasmat
level
rang
ngml
gener
detect
heterozyg
patient
ao
genotyp
instead
homozyg
variant
allel
usual
present
low
concentr
ngml
similarli
haplotyp
includ
mutat
promot
region
associ
signific
reduct
mbl
protein
product
activ
howev
even
though
degre
mbl
defici
strictli
depend
upon
patient
genotyp
case
low
mbl
plasmat
level
also
associ
wildtyp
gene
gene
alreadi
present
earli
invertebr
fifti
million
year
ago
highli
conserv
throughout
anim
human
evolut
would
suggest
correct
function
mbl
protein
crucial
surviv
live
anim
speci
interest
note
geograph
distribut
differ
allel
b
variant
predomin
eurasian
popul
c
variant
mainli
among
asian
america
indian
haplotyp
seem
frequent
express
caucasian
region
particular
distribut
might
link
initi
human
migrat
tabl
mbl
defici
suscept
diseas
human
anim
studi
vi
hsv
africa
induc
specif
advantag
due
mbl
defici
exampl
high
mbl
product
observ
associ
higher
incid
preterm
birth
instead
moder
low
level
could
protect
organ
mycobacteria
system
infect
complement
induc
inflammatorymedi
damag
diseas
ie
meningococcemia
rheumatoid
arthriti
addit
sporad
report
found
clear
associ
mbl
defici
increas
rate
infecti
episod
wide
rang
clinic
effect
link
mbl
haplotyp
also
attribut
role
associ
mutat
gene
encod
protein
similar
function
ie
lficolin
surfact
protein
howev
date
data
upon
clinic
role
combin
defici
preval
mutat
one
gene
allel
relev
rang
analyz
popul
last
twenti
year
increas
bodi
evid
indic
mbl
deficit
due
specif
haplotyp
gener
increas
frequenc
sever
infecti
episod
tabl
howev
structur
immun
system
redund
may
explain
mani
case
polymorph
gene
observ
influenc
suscept
infect
role
lectin
particularli
relev
adapt
immun
system
immatur
compromis
casecontrol
studi
upon
infant
lower
mbl
cord
blood
concentr
associ
higher
incid
gramneg
sepsi
observ
cohort
studi
upon
pediatr
icu
patient
identifi
gene
exon
polymorph
main
determin
progress
sepsi
septic
shock
addit
incid
outcom
sever
infect
appear
influenc
level
activ
mannosebind
lectin
cohort
leukem
patient
undergo
chemotherapi
sever
infect
bacteremia
pneumonia
occur
frequent
individu
lower
mbl
concentr
ethnic
homogen
english
popul
homozygot
mbl
codon
variant
allel
show
significantli
higher
risk
invas
infect
due
streptococcu
pneumonia
captain
men
death
similarli
allel
variant
gene
seem
associ
increas
suscept
meningococc
diseas
among
respiratori
tract
infect
independ
causal
pathogen
mbl
insuffici
observ
predispos
higher
sever
poor
outcom
even
though
legionella
spp
act
intracellular
pathogen
mbl
function
lower
infect
case
australian
legionnair
diseas
outbreak
increas
suscept
wors
outcom
caucasian
patient
acut
respiratori
distress
syndrom
ard
also
observ
presenc
gene
polymorph
regard
virus
chines
popul
presenc
gene
b
variant
associ
increas
risk
coronaviru
infect
instead
normal
mbl
function
seem
worsen
pandem
avian
infect
potenti
upregul
inflammatori
respons
furthermor
recent
larg
retrospect
studi
involv
donorrecipi
orthotop
liver
transplant
pair
patient
receiv
mbldefici
liver
show
threefold
increas
risk
clinic
signific
infect
includ
cytomegalovirusrel
diseas
author
studi
role
mbl
sever
fungal
infect
polymorph
gene
observ
seven
ten
white
patient
chronic
necrot
aspergillosi
compar
control
addit
variat
mbl
plasmat
level
seem
correl
occurr
invas
candidiasi
mbl
genet
plasmat
function
profil
investig
numer
clinic
set
obtain
differ
result
critic
ill
patient
affect
sever
infect
sever
sepsi
septic
shock
might
field
particular
interest
better
knowledg
clinic
relev
possibl
develop
novel
therapeut
strategi
mannosebind
lectin
part
innat
recognit
system
invas
pathogen
effect
modul
cytokin
product
macrophag
phagocytosi
effect
upon
interleukin
il
tumor
necrosi
factor
clearli
shown
ex
vivo
model
immedi
immun
respons
neisseria
meningitidi
infect
mbl
defici
may
associ
unbalanc
proinflammatori
respons
infect
noninfect
trigger
cohort
critic
ill
pediatr
patient
fidler
cowork
observ
mbl
level
less
ngml
consist
gene
exon
polymorph
significantli
increas
risk
develop
system
inflammatori
respons
syndrom
sir
progress
sever
sepsissept
shock
addit
patient
sir
mbl
insuffici
degre
observ
correl
sever
system
infect
accord
genet
profil
associ
defici
protein
wors
outcom
sever
system
infect
ie
evolut
refractori
septic
shock
may
also
relat
signific
interact
complement
activ
inflammatori
cytokin
storm
coagul
cascad
influenc
complement
activ
upon
septic
shock
develop
larg
investig
mani
studi
shown
classic
altern
pathway
activ
septic
shock
involv
mechan
aim
clear
endotoxin
role
recent
studi
also
lectin
complement
activ
due
mbl
dissemin
intravascular
coagul
dic
may
worsen
cours
septic
shock
occurr
sever
complic
unpredict
howev
recent
data
suggest
mbl
deficit
may
signific
risk
factor
earli
develop
dic
organ
failur
sever
infect
convers
excess
mbl
express
might
harm
sinc
molecul
may
contribut
pathogenesi
inflammatori
induc
vascular
damag
organ
failur
observ
patient
undergo
solid
organ
transplant
henc
mbl
due
pivot
role
crosstalk
among
complement
activ
coagul
system
inflamm
may
repres
key
point
understand
develop
system
sever
infect
interestingli
investig
anim
model
clinic
studi
involv
patient
sever
sepsissept
shock
even
though
mani
differ
anim
model
human
limit
translational
preclin
data
sever
mous
experi
support
role
mbl
defici
sever
infect
especi
bacteria
inocul
two
function
mbl
gene
exist
mous
gener
doubl
knockout
genedefici
mice
increas
investig
field
inocul
cfu
staphylococcu
aureu
mblnull
mice
show
hour
mortal
compar
wildtyp
wt
mice
surviv
percentag
addit
pretreat
mblnull
mice
rhmbl
increas
surviv
rate
anoth
model
mbl
andor
masp
defici
mice
takahashi
cowork
observ
defici
associ
earli
occurr
dic
liver
injuri
aureu
inocul
suggest
role
protein
develop
organ
failur
system
coagul
activ
sever
infect
anoth
studi
demonstr
mbl
abl
strongli
bind
oantigen
region
lp
contribut
mice
platelet
activ
rapid
occurr
septic
shock
suscept
mbl
null
mice
pseudomona
aeruginosa
postburn
infect
also
investig
mblnull
mice
burn
bacteri
inocul
earli
develop
septic
shock
die
instead
major
wt
anim
twothird
surviv
observ
underlin
relev
innat
immun
mannosebind
lectin
suscept
outcom
sever
bacteri
infect
occur
popul
regard
fungal
diseas
protect
role
lectin
also
observ
murin
model
invas
pulmonari
aspergillosi
ex
vivo
mbl
administr
howev
lectin
pathway
activ
depend
mbl
function
author
observ
defici
mice
model
without
capabl
activ
mblindepend
lectin
cascad
ie
ficolin
collectin
suscept
develop
sever
system
pneumococc
infect
although
literatur
evid
obtain
anim
studi
support
import
mbl
acquisit
outcom
sever
infect
observ
due
unresolv
sever
limit
anim
studi
may
consid
conclus
strongli
need
clinic
human
studi
definit
identifi
clinic
relev
studi
mbl
key
role
part
innat
immun
reason
haplotyp
associ
defici
mainli
influenc
infecti
episod
involv
neonat
children
immunosuppress
adult
populationbas
prospect
studi
perform
greenland
upon
almost
eskimo
children
heterozyg
homozyg
subject
age
month
variant
allel
present
twofold
increas
risk
acut
respiratori
infect
includ
pneumonia
addit
capoluongo
colleagu
analyz
preterm
newborn
identifi
two
gene
variant
independ
risk
factor
associ
unfavor
outcom
includ
higher
bronchopulmonari
dysplasia
preval
turkish
author
investig
possibl
relationship
cord
blood
mbl
level
neonat
sepsi
result
indic
lower
mbl
level
fetal
inflammatori
respons
syndrom
fir
associ
higher
risk
sepsi
develop
independ
gestat
age
birth
weight
anoth
prospect
studi
conduct
neonat
preterm
show
lowest
mbl
level
detect
infant
septic
shock
especi
case
fatal
outcom
relev
sensit
specif
posit
neg
predict
valu
detect
sepsi
episod
also
document
recent
swiss
investig
mbl
level
detect
cord
blood
newborn
fortyseven
develop
sepsi
within
first
hour
life
requir
catecholamin
septic
shock
exclud
infant
underw
surgeri
low
mbl
concentr
result
independ
associ
increas
risk
earlyonset
gramneg
sepsi
pediatr
oncolog
patient
mbl
defici
associ
suscept
poor
outcom
durat
febril
neutropen
episod
prospect
studi
mbl
deficit
observ
increas
sever
diseas
pediatr
icu
admiss
febril
neutropenia
addit
also
mblrelat
protein
deficit
mediat
inflamm
investig
set
cohort
children
treat
chemotherapi
cancer
deficit
ngml
significantli
increas
risk
febril
neutropenia
bacteraemia
develop
prolong
cumul
durat
hospit
antimicrobi
treatment
import
mbl
function
first
month
life
efficaci
innat
immun
crucial
induc
author
propos
dose
part
biomark
panel
earli
detect
sever
neonat
infect
lowresourc
set
impair
innat
immun
mechan
may
also
increas
risk
nosocomi
infect
critic
ill
patient
observ
sutherland
colleagu
genet
associ
studi
author
identifi
relationship
snp
cd
mbl
tolllik
increas
preval
posit
cultur
sepsi
cohort
adult
septic
patient
mbl
defici
result
also
independ
associ
higher
sequenti
organ
failur
assess
sofa
score
day
suggest
role
risk
factor
develop
sever
sepsi
septic
shock
addit
multicent
prospect
studi
involv
eight
adult
icu
u
k
associ
exon
promot
polymorph
outcom
patient
affect
sever
sepsi
septic
shock
studi
compar
healthi
subject
mbl
defici
patient
increas
risk
sepsi
signific
higher
mortal
rate
presenc
level
ngml
versu
sever
sepsi
septic
shock
increas
mbl
plasmat
level
acut
phase
respons
molecul
may
differ
report
adult
critic
ill
patient
dean
colleagu
observ
regardless
genotyp
patient
mbl
defici
studi
entri
abl
reach
normal
plasmat
level
sever
sepsi
septic
shock
furthermor
wellconduct
prospect
studi
perform
denmark
investig
mbl
genet
plasmat
profil
popul
critic
ill
icu
patient
document
sir
among
enrol
patient
met
criteria
sever
sepsi
septic
shock
compar
noninfecti
sir
patient
share
carriag
mbl
variant
allel
low
serum
level
accord
sever
diseas
anoth
recent
korean
studi
icu
patient
investig
whether
gene
polymorph
serum
level
might
influenc
sever
prognosi
sepsi
author
compar
septic
patient
healthi
control
analyz
three
snp
dose
mbl
serum
level
day
one
among
sepsi
group
homozygosi
polymorph
codon
aa
result
signific
risk
factor
sever
sepsi
develop
mbl
serum
level
mcgml
associ
lower
mortal
rate
septic
shock
group
role
mbl
defici
critic
ill
patient
sever
pneumonia
still
lead
caus
death
due
infecti
diseas
investig
mani
author
larg
casecontrol
studi
patient
affect
communityacquir
pneumonia
cap
compar
healthi
control
subject
patient
without
relev
infecti
diseas
haplotyp
equal
distribut
among
subject
multivari
analysi
mbl
defici
associ
poor
outcom
measur
ie
sever
sepsi
acut
respiratori
failur
multiorgan
dysfunct
syndrom
death
eisen
colleagu
reanalyz
data
six
studi
involv
patient
affect
sever
infect
first
author
defin
mbl
cutoff
valu
mcgml
reliabl
predictor
low
produc
statu
neg
predict
valu
confirm
mbl
defici
significantli
increas
risk
death
due
sever
infect
also
icu
set
especi
streptococcu
pneumonia
invas
caus
agent
odd
ratio
confid
interv
associ
mbl
defici
pneumonia
invas
infect
outcom
recent
investig
spanish
prospect
cohort
studi
studi
period
patient
invas
pneumococc
infect
enrol
rate
allel
variant
snp
aooo
septic
shock
factor
independ
associ
inhospit
mortal
otherwis
earli
adequ
antibiot
dose
hour
result
signific
protect
determin
mbl
defici
role
also
studi
system
infect
due
specif
organ
resman
colleagu
recent
describ
case
necrot
myositi
septic
shock
due
haemophilu
influenza
patient
mbl
defici
diagnos
wellconduct
prospect
studi
correl
gene
polymorph
outcom
escherichia
coli
pyelonephr
investig
although
associ
found
incid
e
coli
infect
presenc
bacteremia
patient
share
lowexpress
genotyp
show
signific
higher
risk
septic
shock
develop
odd
ratio
confid
interv
final
nonbacteri
sever
system
infect
invas
candidiasi
ic
especi
candidemia
still
remain
lead
caus
death
due
infect
critic
ill
patient
serum
mbl
level
measur
patient
proven
ic
hospit
infect
patient
healthi
subject
even
though
mbl
concentr
significantli
higher
ic
patient
control
author
identifi
mark
decreas
plasmat
level
first
day
infect
associ
mannan
increas
observ
although
limit
suggest
crucial
role
mbl
also
earli
phase
candidiasi
therapi
mbl
substitut
therapi
patient
recogn
lectin
deficit
propos
apart
genet
analys
antigen
measur
wide
diffus
diagnost
test
even
though
mbl
serum
level
ngml
mbl
activ
uml
may
consid
signific
defici
standard
guidelin
aim
defin
patient
categori
need
test
ie
presenc
sever
recurr
respiratori
infect
acquir
immunesuppress
recombin
human
mbl
use
supplement
mbl
defici
statu
investig
anim
phase
iii
human
studi
although
clinic
efficaci
clearli
establish
still
advers
effect
observ
sixtyf
mbl
infus
given
mbl
defici
chemotherapyinduc
neutropen
children
observ
postadministr
level
mcgml
rang
may
consid
protect
similar
pharmacokinet
profil
observ
healthi
mbldefici
volunt
two
patient
staphylococcu
aureu
septicemia
howev
beyond
preliminari
observ
mbl
replac
need
investig
defici
patient
affect
acut
sever
infect
especi
presenc
multiplelevel
immun
system
impair
increas
bodi
data
support
role
mbl
central
player
innat
immun
sever
gene
polymorph
identifi
associ
decreas
serum
level
activ
mani
author
show
associ
molecul
deficit
recurr
sever
infect
particularli
involv
respiratori
tract
encapsul
bacteria
addit
grow
evid
suggest
import
system
sever
infect
sever
sepsi
septic
shock
correl
might
deriv
crosstalk
among
complement
system
coagul
pattern
proinflammatori
cytokin
even
though
mani
patient
system
infect
present
mbl
serum
level
function
threshold
higher
risk
develop
sever
complic
poor
outcom
ie
septic
shock
multipl
organ
failur
case
low
level
appear
protect
probabl
reduc
inflammatori
cytokin
storm
moreov
publish
studi
identifi
clear
associ
defici
increas
risk
infect
replac
therapi
recombin
human
protein
sever
sepsi
septic
shock
affect
defici
patient
propos
still
remain
experiment
treatment
henc
new
promis
robust
data
avail
strict
adher
current
standard
recommend
still
remain
mainstay
sever
sepsissept
shock
manag
